A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus
Study Details
Study Description
Brief Summary
The purpose of this clinical research study is to learn if BMS-512148 is effective in controlling blood sugar levels as determined by HbA1c and fasting plasma glucose in patients who have been diagnosed with Type 2 diabetes. Patients should first try to control their diabetes with diet and exercise and should not have previously been treated for their diabetes (very short periods of time are acceptable). The safety of BMS512148 will also be studied
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 2 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Arm 1
|
Drug: dapagliflozin
Tablets, Oral, 2.5 mg, Once daily, 12 weeks.
|
Experimental: Arm 2
|
Drug: dapagliflozin
Tablets, Oral, 5 mg, Once daily, 12 weeks.
|
Experimental: Arm 3
|
Drug: dapagliflozin
Tablets, Oral, 10 mg, Once daily, 12 weeks.
|
Experimental: Arm 4
|
Drug: dapagliflozin
Tablets, Oral, 20 mg, Once daily, 12 weeks.
|
Experimental: Arm 5
|
Drug: dapagliflozin
Tablets, Oral, 50 mg, Once daily, 12 weeks.
|
Placebo Comparator: Arm 6
|
Drug: placebo
Tablets, Oral, 0 mg, Once daily, 12 weeks.
|
Active Comparator: Arm 7
|
Drug: metformin
Tablets, Oral, >/= 1500 mg, Once daily, 12 weeks.
|
Outcome Measures
Primary Outcome Measures
- Mean change from baseline in HbA1c compared to placebo. [at 12 weeks]
Secondary Outcome Measures
- Mean change from baseline in fasting plasma glucose, evaluate proportion of subjects who achieve a therapeutic response (HbA1c <7%); change from baseline in urinary glucose excretion [at Weeks 6 and 12]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients with Type 2 diabetes mellitus with inadequate glycemic control on diet and exercise. HbA1c >= 7% and <=10%.
-
Patient either has not been previously treated with antihyperglycemic medication or has been treated for <30 days since diagnosis and has received less than 3 consecutive doses or 7 non-consecutive doses in the last 30 days.
-
C-peptide > 1.0 ng/ml
-
Body Mass Index <= 40 kg/m2
-
Serum creatinine < 1.5 mg/dL for men or < 1.4 mg/dL for women.
-
No overt proteinuria (microalbumin/creatinine ratio must be <300 mg/g
Exclusion Criteria:
-
Unstable renal disease
-
Patients with significant liver disease including chronic active hepatitis
-
Within the last 6 months has had any of the following cardiovascular event: myocardial infarction, unstable angina, unstable CHF,NYHA Class III or IV CHF, TIA, unstable arrhythmia or cardiac revascularization surgery.
-
Subjects with clinically significant anemia
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Local Institution | Bayou La Batre | Alabama | United States | |
2 | Local Institution | Birmingham | Alabama | United States | |
3 | Local Institution | Huntsville | Alabama | United States | |
4 | Local Institution | Mobile | Alabama | United States | |
5 | Local Institution | Chandler | Arizona | United States | |
6 | Local Institution | Tucson | Arizona | United States | |
7 | Local Institution | Fayetteville | Arkansas | United States | |
8 | Local Institution | Hot Springs | Arkansas | United States | |
9 | Local Institution | Beverly Hills | California | United States | |
10 | Local Institution | Long Beach | California | United States | |
11 | Local Institution | Los Gatos | California | United States | |
12 | Local Institution | Mission Viejo | California | United States | |
13 | Local Institution | Orange | California | United States | |
14 | Local Institution | Redondo Beach | California | United States | |
15 | Local Institution | San Diego | California | United States | |
16 | Local Institution | Torrance | California | United States | |
17 | Local Institution | Colorado Springs | Colorado | United States | |
18 | Local Institution | Denver | Colorado | United States | |
19 | Local Institution | Boynton Beach | Florida | United States | |
20 | Local Institution | Brandon | Florida | United States | |
21 | Local Institution | Delray Beach | Florida | United States | |
22 | Local Institution | Holly Hill | Florida | United States | |
23 | Local Institution | Jacksonville | Florida | United States | |
24 | Local Instiuttion | Jacksonville | Florida | United States | |
25 | Local Institution | New Port Richey | Florida | United States | |
26 | Local Institution | Orlando | Florida | United States | |
27 | Local Institution | Ormond Beach | Florida | United States | |
28 | Local Institution | Augusta | Georgia | United States | |
29 | Local Institution | Blue Ridge | Georgia | United States | |
30 | Local Institution | Honolulu | Hawaii | United States | |
31 | Local Institution | Indianapolis | Indiana | United States | |
32 | Local Institution | Lafayette | Indiana | United States | |
33 | Local Institution | Arkansas City | Kansas | United States | |
34 | Local Institution | Baton Rouge | Louisiana | United States | |
35 | Local Institution | Columbia | Maryland | United States | |
36 | Local Institution | Elkton | Maryland | United States | |
37 | Local Institution | Sudbury | Massachusetts | United States | |
38 | Local Institution | Worcester | Massachusetts | United States | |
39 | Local Institution | Dearborn | Michigan | United States | |
40 | Local Institution | Royal Oak | Michigan | United States | |
41 | Local Institution | Brooklyn Center | Minnesota | United States | |
42 | Local Insitution | Edina | Minnesota | United States | |
43 | Local Institution | Minneapolis | Minnesota | United States | |
44 | Local Institution | Hattiesburg | Mississippi | United States | |
45 | Local Institution | Jackson | Mississippi | United States | |
46 | Local Institution | Chesterfield | Missouri | United States | |
47 | Local Institution | Kansas City | Missouri | United States | |
48 | Local Institution | St. Louis | Missouri | United States | |
49 | Local Institution | Scottsbluff | Nebraska | United States | |
50 | Local Institution | North Las Vegas | Nevada | United States | |
51 | Local Institution | Albuquerque | New Mexico | United States | |
52 | Local Institution | Alburquerque | New Mexico | United States | |
53 | Local Institution | Los Alamos | New Mexico | United States | |
54 | Local Institution | Albany | New York | United States | |
55 | Local Institution | Bronxville | New York | United States | |
56 | Local Institution | Camillus | New York | United States | |
57 | Local Institution | Cooperstown | New York | United States | |
58 | Local Instiution | New Hyde Park | New York | United States | |
59 | Local Institution | West Seneca | New York | United States | |
60 | Local Institution | Charlotte | North Carolina | United States | |
61 | Local Institution | High Point | North Carolina | United States | |
62 | Local Institution | Morehead City | North Carolina | United States | |
63 | Local Institution | Raleigh | North Carolina | United States | |
64 | Local Institution | Wilmington | North Carolina | United States | |
65 | Local Institution | Akron | Ohio | United States | |
66 | Local Institution | Beachwood | Ohio | United States | |
67 | Local Institution | Cincinnati | Ohio | United States | |
68 | Local Institution | Cleveland | Ohio | United States | |
69 | Local Institution | Dayton | Ohio | United States | |
70 | Local Institution | Mogadore | Ohio | United States | |
71 | Local Institution | Newark | Ohio | United States | |
72 | Local Institution | Zanesville | Ohio | United States | |
73 | Local Institution | Bethany | Oklahoma | United States | |
74 | Local Institution | Yukon | Oklahoma | United States | |
75 | Local Institution | Bend | Oregon | United States | |
76 | Local Institution | Eugene | Oregon | United States | |
77 | Local Institution | Hillsboro | Oregon | United States | |
78 | Local Institution | Portland | Oregon | United States | |
79 | Local Institution | Bensalem | Pennsylvania | United States | |
80 | Local Institution | Feasterville | Pennsylvania | United States | |
81 | Local Institution | Levittown | Pennsylvania | United States | |
82 | Local Institution | Morrisville | Pennsylvania | United States | |
83 | Local Institution | Reading | Pennsylvania | United States | |
84 | Local Institution | Cumberland | Rhode Island | United States | |
85 | Local Institution | Johnston | Rhode Island | United States | |
86 | Local Institution | Anderson | South Carolina | United States | |
87 | Local Institution | Simpsonville | South Carolina | United States | |
88 | Local Institution | Summerville | South Carolina | United States | |
89 | Local Institution | Taylors | South Carolina | United States | |
90 | Local Institution | Rapid City | South Dakota | United States | |
91 | Local Institution | Memphis | Tennessee | United States | |
92 | Local Institution | Nashville | Tennessee | United States | |
93 | Local Institution | Selmer | Tennessee | United States | |
94 | Local Institution | Austin | Texas | United States | |
95 | Local Institution | Bellaire | Texas | United States | |
96 | Local Institution | Bryan | Texas | United States | |
97 | Local Institution | El Paso | Texas | United States | |
98 | Local Institution | Houston | Texas | United States | |
99 | Local Institution | Irving | Texas | United States | |
100 | Local Institution | San Antonio | Texas | United States | |
101 | Local Institution | Salt Lake City | Utah | United States | |
102 | Local Institution | Burke | Virginia | United States | |
103 | Local Institution | Hampton | Virginia | United States | |
104 | Local Institution | Norfolk | Virginia | United States | |
105 | Local Institution | Richmond | Virginia | United States | |
106 | Local Institution | Virginia Beach | Virginia | United States | |
107 | Local Institution | Edmonds | Washington | United States | |
108 | Local Institution | Renton | Washington | United States | |
109 | Local Institution | Spokane | Washington | United States | |
110 | Local Institution | Vancouver | Washington | United States | |
111 | Local Institution | Milwaukee | Wisconsin | United States | |
112 | Local Institution | West Allis | Wisconsin | United States | |
113 | Local Institution | Calgary | Alberta | Canada | |
114 | Local Institution | Edmonton | Alberta | Canada | |
115 | Local Institution | Langley | British Columbia | Canada | |
116 | Local Institution | Surrey | British Columbia | Canada | |
117 | Local Institution | Vancouver | British Columbia | Canada | |
118 | Local Institution | Winnipeg | Manitoba | Canada | |
119 | Local institution | Bathurst | New Brunswick | Canada | |
120 | Local Institution | Moncton | New Brunswick | Canada | |
121 | Local Institution | St. John's | New Brunswick | Canada | |
122 | Local Institution | St. John's | Newfoundland and Labrador | Canada | |
123 | Local Institution | Corunna | Ontario | Canada | |
124 | Local Institution | Etobicoke | Ontario | Canada | |
125 | Local Institution | Kitchener | Ontario | Canada | |
126 | Local Institution | Newmarket | Ontario | Canada | |
127 | Local Institution | Sarnia | Ontario | Canada | |
128 | Local Institution | Toronto | Ontario | Canada | |
129 | Local Institution | Charlottetown | Prince Edward Island | Canada | |
130 | Local Institution | Drummondville | Quebec | Canada | |
131 | Local Institution | Granby | Quebec | Canada | |
132 | Local Institution | Greenfield Park | Quebec | Canada | |
133 | Local Institution | Rimouski | Quebec | Canada | |
134 | Local Institution | St-Leonard | Quebec | Canada | |
135 | Local Institution | Ste-Foy | Quebec | Canada | |
136 | Local Institution | Saskatoon | Saskatchewan | Canada | |
137 | Local Institution | Guadalajara | Jalisco | Mexico | |
138 | Local Institution | Zapopan | Jalisco | Mexico | |
139 | Local Institution | Cuernavaca | Morelos | Mexico | |
140 | Local Institution | Monterrey | Nuevo Leon | Mexico | |
141 | Local Institution | Aguascalientes | Mexico | ||
142 | Local Institution | Durango | Mexico | ||
143 | Local Institution | Caguas | Puerto Rico | ||
144 | Local Institution | Manati | Puerto Rico | ||
145 | Local Institution | San Juan | Puerto Rico |
Sponsors and Collaborators
- AstraZeneca
- Bristol-Myers Squibb
Investigators
- Study Director: Bristol Myers Squibb, Bristol-Myers Squibb
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- MB102-008